Get startedLog in
    Picture of Medexus Pharmaceuticals logo

    MDP — Medexus Pharmaceuticals News Story

    0.000.00%
    ca flag iconLast trade - 00:00
    HealthcareAdventurousSmall CapSuper Stock
    All News

    Brief: Medexus Reports Health Canada Approval Of Gleolan® (5-Ala) For Use In Guided Surgical Resection Of High-Grade Gliomas

    Picture of Medexus Pharmaceuticals logoMedexus Pharmaceuticals
    10/09/2020 14:44
    Sept 10 (Reuters) - Medexus Pharmaceuticals Inc  MDP.V :
    * MEDEXUS REPORTS HEALTH CANADA APPROVAL OF GLEOLAN® (5-ALA)
FOR
USE IN GUIDED SURGICAL RESECTION OF HIGH-GRADE GLIOMAS

Source text for Eikon:  ID:nGNXPcv2Z 
Further company coverage:  MDP.V 

 ((Reuters.Briefs@thomsonreuters.com;))

    Recent news on Medexus Pharmaceuticals

    See all news